Saffron

Saffron is a 8.0–8.5/10 fit for people using mood, depression, and sleep quality as a measured experiment, not a belief-based staple. The best anchors are Kell et al. 2017, which reports 128 adults and 28 mg/day improved negative mood, stress, anxiety, and sleep-quality measures versus placebo, and Mahmoudi et al. 2026, which reports 34 randomized trials, 1769 participants and improved self-reported BDI and BAI scores but not all clinician-rated HDRS, HARS, or POMS endpoints. That gives Saffron a real signal, but the report should stay narrow because responder fit, baseline status, and outcome tracking drive the practical value. Use Saffron when the target is specific, measurable, and worth the tradeoff. Skip or stop Saffron when the expected symptom, lab, or performance marker stays flat.

✅ Best for: Adults with mild-to-moderate low mood, stress sensitivity, or sleep fragmentation who want a low-friction botanical adjunct; women with PMS or PMDD patterns who are not pregnant or trying to conceive; adults with early dry AMD who want to discuss 20 mg/day saffron with a retinal specialist; SSRI users with sexual-function concerns only under clinician guidance; stack-builders who tolerate serotonergic botanicals poorly but find saffron subjectively smoother. Nick's use case, mood and creative-thinking support inside multi-ingredient stacks, is a representative good-fit pattern rather than a guaranteed standalone effect.

❌ Avoid if: Pregnant, trying to conceive, or not using contraception where pregnancy is possible; history of bipolar disorder, mania, or hypomania; current MAOI use; unsupervised stacking with SSRIs, SNRIs, bupropion, 5-HTP, or St. John's Wort; warfarin use, active bleeding disorder, or upcoming surgery; severe depression, suicidal ideation, wet AMD, advanced AMD, or uncontrolled metabolic disease where saffron would delay standard care. Also avoid unverified loose stigma or bargain extracts because saffron adulteration can turn a low-risk supplement into a quality-control problem.